Previous Seminars and Events
Previous Seminars and Events
Details of our previous seminars and events are listed below:
CCRCB Seminars 2016-17
| Date | Speaker | Institution | Title |
|---|---|---|---|
| 26/05/2017 | Dr Cristina Branco | University of Cambridge | Host physiology and compliance with cancer dissemination: factoring cells, isoforms and time |
| 18/05/2017 | Dr Colin Adrain | IGC, Lisbon, Portugal | Regulation of the ADAM17 pathway during inflammation, growth factor signaling and metabolism |
| 04/05/2017 | Professor Padraic Fallon | Trinity College Dublin | Translating the atopy march: a tail of mice and men |
| 28/04/2017 | Professor Jim Johnston | Fusion Antibodies Ltd | Bugs, BiTEs, viruses and vaccines; novel approaches to cancer therapy |
| 27/04/2017 | Professor Vlad Popovici | Masaryk University, Brno, Czech Republic | Case studies in tissue-based proxy biomarkers |
| 30/03/2017 | Dr Fiona Frame | University of York | Tumour heterogeneity and therapy resistance - implications for future treatments of prostate cancer |
| 23/03/2017 | Professor Corrado Santocanale | NUI Galway | DNA replication, chemical genetics and cellular responses to CDC7 kinase inhibitors |
| 08/03/2017 | Kirk Mundy | Senior Director, Woldwide Clinical Marketing. Mitra Biotech, Inc. | Powerful Predictions for Truly Personalized Cancer Care |
| 02/03/2017 | Dr Claudio Isella |
University of Torino, Italy |
Dissecting the colorectal transcriptome: stromal components and epithelial subtypes associated with prognosis and response to treatment |
| 02/02/2017 | Dr Amaya Viros |
University of Manchester |
Melanoma gene-environment interactions and personalised care |
| 26/01/2017 | Dr Crispin Miller |
University of Manchester |
Big data, gene networks, and oncogenic meta-drivers reveal the single-cell origins of cancer |
| 19/01/2017 | Dr Nick Cross |
University of Southampton |
Genetic complexity in myeloproliferative neoplasms (MPN)" |
| 01/12/2016 | Professor Ciaran Morrison |
NUI Galway |
Centrosome proteins involved in ciliogenesis and DNA damage response |
| 23/11/16 | Dr Ester Hammond |
CR-UK /MRC Oxford Institute for Radiation Oncology, University of Oxford |
Hypoxia-induced replication stress: causes, consequences and opportunities |
| 10/11/16 | Dr Alessio Ciulli | University of Dundee | Drugging VHL with small molecules: chemical probes of hypoxia signalling and E3 ligase ligands for targeted protein degradation |
| 20/10/2016 | Dr Gary Newton | Domainex | Facilitating Academic Discovery: The Discovery of Der p 1 Inhibitors for treatment of Asthma |
| 19/10/2016 | Professor Corinne Faivre-Finn | Christie Hospital & University of Manchester | The management of lung cancer with radiotherapy: current standards of care and the imperative for change |
|
13/10/2016 *CRUK Seminar |
Professor Ruth Plummer | Newcastle University | Taking cancer drugs into the clinic - pitfalls and eventual success |
CRUK Centre Lectures 2009 - 2016
| Year | Speaker | Institution | Title |
|---|---|---|---|
| 2016 | Professor Ruth Plummer | Northern Institute for Cancer Research, Newcastle University | Taking cancer drugs into the clinic – pitfalls and eventual success |
| 2015 | Professor Richard Marais | CRUK Manchester Institute | Precision Medicine in Melanoma |
| 2014 | Professor Bob Brown | Imperial College London | Epigenetic drivers of the cancer patient journey through the epigenome landscape |
| 2013 | Professor Laura Machesky | Beatson Institute for Cancer Research | Role of the actin bundling protein fascin in pancreatic cancer invasion and metastasis |
| 2012 | Dr Jason Carroll | Cambridge Research Institute | Understanding Estrogen Receptor Transcription in Breast Cancer |
| 2011 | Professor Steve Jackson | The Gurdon Institute, University of Cambridge | Cellular responses to DNA damage: From molecular insights to new approaches for cancer therapy |
| 2011 | Dr Andrew Tutt | Director, Breakthrough Breast Cancer Research Unit, Kings College London | Targeting the DNA Damage Response in Triple Negative Breast: Platinums and PARPS - An Update |
| 2010 | Professor Mariano Barbacid | Director, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain | Targeting K-Ras signalling pathways in cancer |
| 2009 | Professor Karen Vousden | Beatson Institute for Cancer Research | Functions of the p53 tumour suppressor protein in the regulation of metabolism and invasion |
Upcoming Events
READ MORE